Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCCAM research funding

This article was originally published in The Tan Sheet

Executive Summary

Roughly 28% of all NIH research applications were funded in FY 2002, while for NCCAM "it was under 14%," center Director Steven Straus tells an Institute of Medicine CAM committee Feb. 27. He noted the discrepancy is because the average cost of an NCCAM application is more than those of most NIH institutes, and NCCAM-funded trials "are more likely to be [large] clinical trials." The IoM CAM committee is charged with evaluating Americans' use of complementary & alternative medicine...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel